发明名称 Therapeutic uses for an aminosterol compound
摘要 A pharmaceutical composition includes, as an active ingredient, a compound according to formula 1436 as shown in FIG. 1, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier or excipient. Various pharmaceutical products may be produced including this pharmaceutical composition. Such pharmaceutical products may be used for the treatment of obesity or diabetes. Methods for using the pharmaceutical compositions also are described. In these methods, various diseases are treated or other body functions are activated or inhibited by administering an effective amount of the pharmaceutical composition. For example, diabetes and obesity may be treated by administering an effective amount of the pharmaceutical compositions. Weight gain, and growth factor production can be inhibited by administering an effective amount of these pharmaceutical compositions. Appetite can be suppressed by administering an effective amount of the pharmaceutical compositions, and a diuretic effect can be produced.
申请公布号 AU3130697(A) 申请公布日期 1997.12.09
申请号 AU19970031306 申请日期 1997.05.16
申请人 MAGAININ PHARMACEUTICALS, INC. 发明人 MICHAEL ZASLOFF;JON WILLIAMS;WILLIAM KINNEY;MARK ANDERSON
分类号 A61K31/575;A61P3/04;A61P7/10;A61P19/02;A61P29/00;A61P31/22;A61P35/00;A61P35/02;A61P43/00;C07J41/00 主分类号 A61K31/575
代理机构 代理人
主权项
地址